Literature DB >> 19692637

A pivotal role of endothelial-specific NF-kappaB signaling in the pathogenesis of septic shock and septic vascular dysfunction.

Jianqiang Ding1, Dongmei Song, Xiaobing Ye, Shu Fang Liu.   

Abstract

Although the role of NF-kappaB in the pathogenesis of sepsis and septic shock has been extensively studied, little is known about the causative contribution of endothelial-intrinsic NF-kappaB to these pathological processes. In this study, we used transgenic (TG) mice (on FVB genetic background) that conditionally overexpress the NF-kappaB inhibitor, mutant I-kappaBalpha, selectively on endothelium and their transgene-negative littermates (wild type (WT)) to define the causative role of endothelial-specific NF-kappaB signaling in septic shock and septic vascular dysfunction. In WT mice, LPS challenge caused systemic hypotension, a significantly blunted vasoconstrictor response to norepinephrine, and an impaired endothelium-dependent vasodilator response to acetylcholine, concomitant with a markedly increased aortic inducible NO synthase expression, significantly elevated plasma and aortic levels of nitrite/nitrate, increased aortic TNF-alpha expression, and decreased aortic endothelial NO synthase (eNOS) expression. In TG mice whose endothelial NF-kappaB was selectively blocked, LPS caused significantly less hypotension and no impairments in vasoconstrictor and endothelium-dependent vasodilator responses, associated with significantly reduced aortic inducible NO synthase expression, decreased plasma and aortic levels of nitrite/nitrate, reduced aortic TNF-alpha expression, and increased aortic eNOS expression. TNF-alpha knockout mice prevented LPS-induced eNOS down-regulation. WT mice subjected to cecal ligation and puncture showed significant systemic hypotension, which was prevented in TG mice. Our data show that selective blockade of endothelial-intrinsic NF-kappaB pathway is sufficient to abrogate the cascades of molecular events that lead to septic shock and septic vascular dysfunction, demonstrating a pivotal role of endothelial-specific NF-kappaB signaling in the pathogenesis of septic shock and septic vascular dysfunction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19692637      PMCID: PMC2907363          DOI: 10.4049/jimmunol.0900105

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

Review 1.  The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome.

Authors:  William C Aird
Journal:  Blood       Date:  2003-01-23       Impact factor: 22.113

2.  Pharmacology of kinins in the arterial and venous mesenteric bed of normal and B2 knockout transgenic mice.

Authors:  N Berthiaume; F Hess; A Chen; D Regoli; P D'Orléans-Juste
Journal:  Eur J Pharmacol       Date:  1997-08-20       Impact factor: 4.432

3.  Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase.

Authors:  F M Faraci; C D Sigmund; E G Shesely; N Maeda; D D Heistad
Journal:  Am J Physiol       Date:  1998-02

4.  In vivo inhibition of nuclear factor-kappa B activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock.

Authors:  S F Liu; X Ye; A B Malik
Journal:  J Immunol       Date:  1997-10-15       Impact factor: 5.422

5.  Inhibition of nuclear factor-kappaB activation by IRFI 042, protects against endotoxin-induced shock.

Authors:  Domenica Altavilla; Giovanni Squadrito; Letteria Minutoli; Barbara Deodato; Antonino Bova; Aurora Sardella; Paolo Seminara; Maria Passaniti; Giuseppe Urna; Saverio F Venuti; Achille P Caputi; Francesco Squadrito
Journal:  Cardiovasc Res       Date:  2002-06       Impact factor: 10.787

Review 6.  NF-kappaB action in sepsis: the innate immune system and the heart.

Authors:  Maria A Brown; W Keith Jones
Journal:  Front Biosci       Date:  2004-05-01

Review 7.  Intact and altered endothelium in regulation of vasomotion.

Authors:  A Lerman; J C Burnett
Journal:  Circulation       Date:  1992-12       Impact factor: 29.690

8.  Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses.

Authors:  W C Sha; H C Liou; E I Tuomanen; D Baltimore
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

9.  Overexpression of CuZn-SOD prevents lipopolysaccharide-induced endothelial dysfunction.

Authors:  Sean P Didion; Dale A Kinzenbaw; Pamela E Fegan; Lisa A Didion; Frank M Faraci
Journal:  Stroke       Date:  2004-06-24       Impact factor: 7.914

10.  Tumor necrosis factor-alpha inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells.

Authors:  Hope D I Anderson; Dolkun Rahmutula; David G Gardner
Journal:  J Biol Chem       Date:  2003-10-27       Impact factor: 5.157

View more
  36 in total

1.  Activation of TNFR1 ectodomain shedding by mitochondrial Ca2+ determines the severity of inflammation in mouse lung microvessels.

Authors:  David J Rowlands; Mohammad Naimul Islam; Shonit R Das; Alice Huertas; Sadiqa K Quadri; Keisuke Horiuchi; Nilufar Inamdar; Memet T Emin; Jens Lindert; Vadim S Ten; Sunita Bhattacharya; Jahar Bhattacharya
Journal:  J Clin Invest       Date:  2011-04-25       Impact factor: 14.808

Review 2.  Emerging concepts regarding pannexin 1 in the vasculature.

Authors:  Miranda E Good; Daniela Begandt; Leon J DeLalio; Alexander S Keller; Marie Billaud; Brant E Isakson
Journal:  Biochem Soc Trans       Date:  2015-06       Impact factor: 5.407

3.  The NF-κB inhibitory proteins IκBα and IκBβ mediate disparate responses to inflammation in fetal pulmonary endothelial cells.

Authors:  Jen-Ruey Tang; Katherine A Michaelis; Eva Nozik-Grayck; Gregory J Seedorf; Marlena Hartman-Filson; Steven H Abman; Clyde J Wright
Journal:  J Immunol       Date:  2013-02-15       Impact factor: 5.422

4.  Spatiotemporal control of porcine p65RHD expression by advanced Tet-On system in PIEC cells helps regulate NFкB activity.

Authors:  Jinxue Ruan; Nan Liu; Hongsheng Ouyang; Shulin Yang; Kui Li
Journal:  Mol Biol Rep       Date:  2014-01-18       Impact factor: 2.316

Review 5.  THE ENDOTHELIUM IN SEPSIS.

Authors:  Can Ince; Philip R Mayeux; Trung Nguyen; Hernando Gomez; John A Kellum; Gustavo A Ospina-Tascón; Glenn Hernandez; Patrick Murray; Daniel De Backer
Journal:  Shock       Date:  2016-03       Impact factor: 3.454

6.  Febrile-range hyperthermia augments lipopolysaccharide-induced lung injury by a mechanism of enhanced alveolar epithelial apoptosis.

Authors:  Anne B Lipke; Gustavo Matute-Bello; Raquel Herrero; Kiyoyasu Kurahashi; Venus A Wong; Stephen M Mongovin; Thomas R Martin
Journal:  J Immunol       Date:  2010-03-03       Impact factor: 5.422

Review 7.  Impact of Immune System Activation and Vascular Impairment on Male and Female Sexual Dysfunction.

Authors:  Fabiano B Calmasini; Nicole Klee; R Clinton Webb; Fernanda Priviero
Journal:  Sex Med Rev       Date:  2019-07-17

8.  Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

Authors:  Thomas E Ichim; Boris Minev; Todd Braciak; Brandon Luna; Ron Hunninghake; Nina A Mikirova; James A Jackson; Michael J Gonzalez; Jorge R Miranda-Massari; Doru T Alexandrescu; Constantin A Dasanu; Vladimir Bogin; Janis Ancans; R Brian Stevens; Boris Markosian; James Koropatnick; Chien-Shing Chen; Neil H Riordan
Journal:  J Transl Med       Date:  2011-03-04       Impact factor: 5.531

9.  Endothelial glucocorticoid receptor is required for protection against sepsis.

Authors:  Julie E Goodwin; Yan Feng; Heino Velazquez; William C Sessa
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

10.  Lipopolysaccharide regulates biosynthesis of cystathionine γ-lyase and hydrogen sulfide through Toll-like receptor-4/p38 and Toll-like receptor-4/NF-κB pathways in macrophages.

Authors:  Yijie Zheng; Naixiang Luo; Dongzhen Mu; Pei Jiang; Ronghua Liu; Haozhe Sun; Shudao Xiong; Xiaoming Liu; Luman Wang; Yiwei Chu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-07-23       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.